The Non-Mevalonate Pathway to Isoprenoid Biosynthesis: A Potential Source of New Drug Targets
Isoprenoids are an essential class of natural products with a myriad of biological functions. All isoprenoids are assembled using two common five-carbon precursors, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) that are biosynthesized via two completely independent ro...
Main Authors: | Anna K. H. Hirsch, François Diederich |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2008-04-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://chimia.ch/chimia/article/view/4467 |
Similar Items
-
Isoprenoid biosynthesis regulation in poplars by methylerythritol phosphate and mevalonic acid pathways
by: Ali Movahedi, et al.
Published: (2022-09-01) -
Human Isoprenoid Synthase Enzymes as Therapeutic Targets
by: Jaeok ePark, et al.
Published: (2014-07-01) -
Genetic Adaptation of a Mevalonate Pathway Deficient Mutant in Staphylococcus aureus
by: Sebastian Reichert, et al.
Published: (2018-07-01) -
Anaerobic Fungal Mevalonate Pathway Genomic Biases Lead to Heterologous Toxicity Underpredicted by Codon Adaptation Indices
by: Ethan T. Hillman, et al.
Published: (2021-09-01) -
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs
by: Emanuela Chiarella, et al.
Published: (2022-05-01)